Redhill Biopharma Statistics
NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.474-0.01 (-2.07%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Redhill Biopharma by the numbers
Redhill Biopharma has a market capitalization of $4.2 million based on 8.89M shares outstanding. With trailing EPS of $0.00, Redhill Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.5% below its 50-day average and 45.9% below its 200-day average.
Average daily trading volume is 1.84M shares, or about $871,301 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RDHL valuation vs. peer median
| Metric | RDHL | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.21M | $3.89M | +8% |
| Avg. volume | 1.84M | 278.01K | +561% |
Peer median across 8 companies: GRI, PCSA, ERNA, SXTP, JUNS, SXTC, EOCN, NCNA.
Valuation
- Market cap
- $4.21M
- Forward P/E
- 15.80
- EPS (TTM)
- $0.00
- Shares outstanding
- 8.89M
Price and trading
- Previous close
- 0.484
- Open
- 0.4712
- Day range
- 0.4712 – 0.4964
- 52-week range
- 0.465 – 2.14
- 50-day moving average
- 0.6112
- 200-day moving average
- 0.8756
- Beta
- —
- Volume
- 34.42K
- Average volume
- 1.84M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 10, 2025
Additional statistics
- Market Cap
- 4.21M
- Forward Pe
- 15.80
- Eps
- 0.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.14
- Week52 Low
- 0.47
- Avg Volume
- 1.84M
- Shares Outstanding
- 8.89M
- Ma50
- 0.61
- Ma200
- 0.88
- Earnings Date
- Apr 10, 2025
- Pct From52w High
- -77.85%
- Pct From52w Low
- 1.94%